Clinical Trials Browser

Phase 2 × Thyroid Carcinoma, Anaplastic × Radiotherapy, Intensity-Modulated × Clear all

NCT04675710 2026-02-19

Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer

Phase 2 Active not recruiting

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT03211117 2020-03-25

Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer

Phase 2 Completed

3 enrolled 7 charts

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic